LA PALMA INTERCOMMUNITY HOSPITAL
1. Target Overview & Investment Thesis
LA PALMA INTERCOMMUNITY HOSPITAL is a 115-bed suburban community hospital in ORANGE, CA with $54.3M in net patient revenue and a -1.7% operating margin. The hospital serves a payer mix of 32.6% Medicare, 9.9% Medicaid, and 57.5% commercial.
Thesis: Undervalued. Our ML models identify $4.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.7% to 5.7% (+736bps).
| Net Revenue HCRIS | $54.3M |
| Current EBITDA COMPUTED | $-924K |
| Operating Margin COMPUTED | -1.7% |
| Occupancy HCRIS | 27.0% |
| Revenue / Bed COMPUTED | $473K |
| Net-to-Gross HCRIS | 28.0% |
| Distress Probability ML | 56.0% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -1.7% places it above the state median. Among 186 size-comparable peers (58-230 beds), the median margin is -4.5%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (58-230), prioritizing same-state peers. 186 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| LA PALMA INTERCOMMUNITY HOSPIT (Target) | CA | 115 | $54.3M | -1.7% |
| CITY OF HOPE NATIONAL MEDICAL | CA | 217 | $1.83B | -10.7% |
| COMMUNITY HOSP. MONTEREY PENIN | CA | 227 | $797.2M | 9.3% |
| KFH - MANTECA | CA | 213 | $796.8M | 15.2% |
| LAC OLIVE VIEW/UCLA MEDICAL CE | CA | 225 | $754.9M | -10.5% |
| CHILDRENS HOSP & RES CNTR OAKL | CA | 155 | $687.9M | -7.1% |
| KFH - WALNUT CREEK | CA | 219 | $681.0M | -3.4% |
| NORTHBAY HOSPITAL GROUP | CA | 204 | $676.6M | -8.2% |
| KFH - SAN LEANDRO | CA | 216 | $663.8M | 10.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $661K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $35K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-924K |
| + RCM Uplift | +$4.0M |
| Pro Forma EBITDA | $3.1M |
| Current Margin | -1.7% |
| Pro Forma Margin | 5.7% |
| WC Released (1x) | $2.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-1.4M | $33.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-1.4M | $36.8M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-1.3M | $49.6M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-1.3M | $53.7M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-1.6M | $14.4M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-1.6M | $15.3M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 27.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 56.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 186 hospitals with 58-230 beds
- Same-state prioritization (n=187)
- Comp margins: P25=-20.3% / P50=-4.5% / P75=4.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.